Does AMBRISENTAN Cause Injection site extravasation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Injection site extravasation have been filed in association with AMBRISENTAN (AMBRISENTAN). This represents 0.0% of all adverse event reports for AMBRISENTAN.
9
Reports of Injection site extravasation with AMBRISENTAN
0.0%
of all AMBRISENTAN reports
2
Deaths
5
Hospitalizations
How Dangerous Is Injection site extravasation From AMBRISENTAN?
Of the 9 reports, 2 (22.2%) resulted in death, 5 (55.6%) required hospitalization, and 1 (11.1%) were considered life-threatening.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMBRISENTAN. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does AMBRISENTAN Cause?
Dyspnoea (13,367)
Death (7,497)
Headache (7,325)
Pneumonia (4,693)
Dizziness (4,561)
Fatigue (4,436)
Diarrhoea (4,312)
Nausea (3,986)
Fluid retention (3,927)
Malaise (3,839)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which AMBRISENTAN Alternatives Have Lower Injection site extravasation Risk?
AMBRISENTAN vs AMBROSIA ARTEMISIIFOLIA POLLEN
AMBRISENTAN vs AMBROXOL
AMBRISENTAN vs AMDINOCILLIN PIVOXIL
AMBRISENTAN vs AMG-510
AMBRISENTAN vs AMIFAMPRIDINE